On November 2, Dogecoin's dollar-margined long position share fell by 2.08 percentage points to 74.92%, while its coin-margined long position and account shares saw minimal changes. Among major cryptocurrencies, Bitcoin's dollar-margined long share increased by 1.42 points to 63.66%, Ethereum's decreased slightly to 59.67%, XRP and Solana showed minor declines and gains respectively. Coin-margined long positions and account shares for these tokens experienced smaller fluctuations. These shifts reflect varying trader sentiment across different contract types in the crypto futures market.
The story on Dogecoin futures trading provides context for cryptocurrency market activity on Pluang. As of Nov 02, 2026 18:41 WIB, 5 out of 50 major cryptocurrencies rose while 44 fell. Notable movers include EOS, which gained 8.13% to Rp12.649, and COTI, which declined 6.58% to Rp184, with a typical hold time of 122 days and a buy order activity of 89%.
The global bio-based construction polymer market, valued at $18.2 billion in 2025, is projected to grow to $35 billion by 2033 at an 8.3% CAGR. Growth is fueled by rising demand for sustainable building materials that reduce greenhouse gas emissions ...
Annual Over-the-Air (OTA) software updates for software-defined vehicles (SDVs) are projected to reach over 2 billion globally by 2035, up from 546 million in 2025, driven by rising SDV sales and advanced vehicle software platforms. Level 3 and above...
Fram Wind Solutions AS, a joint venture partly owned by BW Offshore, secured a NOK 1.94 billion grant from Enova to develop a floating offshore wind project featuring two 18.5 MW turbines, the largest globally, with a combined capacity of 37 MW. The ...
Thailand's textile market is projected to grow from USD 4.97 billion in 2026 to USD 5.39 billion by 2032, at a CAGR of 1.31%. Growth is fueled by domestic fiber production, machinery upgrades, and rising demand for faster garment replenishment, espec...
Callan JMB has received and will install a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics at its Texas facility, marking a key step in expanding its domestic pharmaceutical manufacturing. This new capability aims to produce f...
